Determinants of the quality of life (QoL) in patients with an implantable cardioverter/defibrillator (ICD)

被引:61
作者
Godemann, F
Butter, C
Lampe, F
Linden, M
Werner, S
Behrens, S
机构
[1] Free Univ Berlin, Klinikum Benjamin Franklin, Dept Psychiat, D-12200 Berlin, Germany
[2] German Heart Ctr, Berlin, Germany
[3] Free Univ Berlin, Klinikum Benjamin Franklin, Dept Cardiol, D-12200 Berlin, Germany
[4] BFA Rehabil Ctr, Dept Behav Med, Teltow, Germany
关键词
anxiety; implantable cardioverter/defibrillator (ICD); quality of life (QoL); SF-36; somatization;
D O I
10.1023/B:QURE.0000018493.32844.56
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objectives: In high-risk cardiac patients the treatment of life-threatening arrhythmias with an implantable cardioverter/defibrillator (ICD) extends survival. Other important outcome criteria are treatment side effects especially the quality of life (QoL). Knowledge of the variables that influence QoL is important for therapy decisions in ICD patients. Methods: Ninety-three ICD patients evaluated their QoL by the SF-36 after 1 - 6 years of ICD implantation. The QoL was studied in relation to cardiac function ( severity of heart failure, ejection fraction), treatment course ( number of shocks), coping styles and psychiatric syndromes. Results: About 30% of the somatic QoL ( physical role function, pain) is determined by the patients' somatization tendency, i.e. the extent to which they suffer from non-specific symptoms ( sweating, weakness in the legs, nausea). The severity of heart failure had little influence on the physical QoL. The emotional QoL is primarily determined by phobic anxiety of ICD patients. Conclusions: Psychiatric symptoms are the most important factors to determine the QoL in ICD patients. Behavioural treatment procedures of phobic anxieties and somatization could improve QoL in ICD patients.
引用
收藏
页码:411 / 416
页数:6
相关论文
共 28 条
  • [1] [Anonymous], 1995, Die Symptom-Checkliste von Derogatis SCL-90-R
  • [2] THE QUALITY-OF-LIFE OF PATIENTS WITH LIFE-THREATENING ARRHYTHMIAS
    ARTEAGA, WJ
    WINDLE, JR
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (19) : 2086 - 2091
  • [3] SOMATIZATION AND MEDICALIZATION IN THE ERA OF MANAGED CARE
    BARSKY, AJ
    BORUS, JF
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (24): : 1931 - 1934
  • [4] BERNHARD J, 1992, LEBENSQUALITAT ONKOL
  • [5] Potential benefit from implantable cardioverter-defibrillator therapy in patients with and without heart failure
    Böcker, D
    Bänsch, D
    Heinecke, A
    Weber, M
    Brunn, J
    Hammel, D
    Borggrefe, M
    Breithardt, G
    Block, P
    [J]. CIRCULATION, 1998, 98 (16) : 1636 - 1643
  • [6] Bullinger M, 1995, SF 36 FRAGEBOGEN GES
  • [7] Predictors of psychosocial adjustment in patients with implantable cardioverter defibrillators
    Burgess, ES
    Quigley, JF
    Moran, G
    Sutton, FJ
    Goodman, M
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1997, 20 (07): : 1790 - 1795
  • [8] Improved appraisal of the quality of life in patients with automatic implantable cardioverter defibrillator - A psychometric study
    Chevalier, P
    Verrier, P
    Kirkorian, G
    Touboul, P
    Cottraux, J
    [J]. PSYCHOTHERAPY AND PSYCHOSOMATICS, 1996, 65 (01) : 49 - 56
  • [9] Dupuy HJ, 1984, ASSESSMENT QUALITY L
  • [10] How different from pacemaker patients are recipients of implantable cardioverter-defibrillators with respect to psychosocial adaptation, affective disorders, and quality of life?
    Duru, F
    Büchi, S
    Klaghofer, R
    Mattmann, H
    Sensky, T
    Buddeberg, C
    Candinas, R
    [J]. HEART, 2001, 85 (04) : 375 - 379